TRICARES

TRiCares' mission is to revolutionize the treatment of tricuspid regurgitation (TR). We are developing Topaz, a minimally invasive tricuspid valve replacement system designed to eliminate TR and improve patient outcomes. Our goal is for Topaz to become the valve of choice for TR treatment, offering a safe and effective solution that overcomes limitations of existing approaches... TRiCares is a global business, with offices in France, Germany, the US and Brazil. Our vision is to bring to market a catheter-based tricuspid valve replacement system that will help patients suffering from severe tricuspid regurgitation (TR) without the need for open-heart surgery... We are a growing team, with diverse skills and experiences, who share the vision of bringing the highest-quality tricuspid regurgitation treatment to market.

Also known as: TriCares GmbH, TRiCares SAS

VAT numbers: DE305851199

Primary location: Munich Germany